XIST and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC), XIST acts as the ceRNA of miR-744, inhibits the feedback loop of miR-744/RING1 and activates the Wnt/ β-catenin signaling pathway, which results in enhanced proliferation of NSCLC cells [37].